Skip to content

Clinical trials

Phase 1 Endometrial Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1 Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20091
20102
20141
20192
20201
20212
20225
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated7
Active, not recruiting4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
Seagen Inc.2
Seagen, a wholly owned subsidiary of Pfizer2
AbbVie1
Alliance for Clinical Trials in Oncology1
AstraZeneca1
Eli Lilly and Company1
Fusion Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms20
Breast Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Ovarian Neoplasms7
Stomach Neoplasms7
Uterine Cervical Neoplasms7
Carcinoma, Renal Cell4
Colorectal Neoplasms4
Esophageal Neoplasms4
Neoplasm Metastasis4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.